Regulatory Compliance Harman Finochem Ltd maintains strict adherence to global standards such as USFDA, ICH Q7A, TGA, PIC, WHO-GMP, Schedule M, and Japanese Foreign Accreditation, positioning it as a reliable partner for pharmaceutical companies seeking compliant active pharmaceutical ingredients (APIs).

Expansion Capabilities With multiple manufacturing sites at Aurangabad and Vapi, the company offers substantial production capacity, enabling it to meet large-scale API requirements and accommodate growing demands from international pharma and generic markets.

Export Expertise Recognized as an 'EXPORT HOUSE' by the Indian government, Harman Finochem has established strong export channels, making it an attractive supplier for global pharmaceutical firms looking for quality APIs with reliable logistics.

Technological Sophistication Equipped with state-of-the-art manufacturing and QC laboratories, including cGMP compliant pilot plants and advanced powder processing techniques, the company is well-positioned to produce high-quality, complex API formulations.

Market Position Generating substantial revenue between $100 million and $250 million and serving major pharma and generic companies, Harman Finochem offers robust sales potential for partners seeking dependable API supply amidst evolving market trends.